{"id":9027,"date":"2024-01-09T14:16:00","date_gmt":"2024-01-09T14:16:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=9027"},"modified":"2024-01-10T09:17:28","modified_gmt":"2024-01-10T09:17:28","slug":"nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo","status":"publish","type":"post","link":"https:\/\/dailyai.com\/de\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","title":{"rendered":"NVIDIA erweitert sein Angebot an Modellen f\u00fcr die Arzneimittelforschung durch BioNeMo"},"content":{"rendered":"

NVIDIA hat neue generative KI-Modelle zu BioNeMo hinzugef\u00fcgt, einem Cloud-Service zur Erstellung und Bereitstellung von KI-Modellen f\u00fcr die Arzneimittelforschung.<\/b><\/p>\n

BioNeMo ist eine generative KI-Plattform, die den Prozess der Arzneimittelentdeckung unterst\u00fctzen soll, f\u00fcr den KI im Jahr 2023 eine enorme Eignung aufweist. <\/span>Es beherbergt eine Reihe von KI-Modellen und Cloud-Diensten, die speziell auf die Arzneimittelentwicklung zugeschnitten sind.<\/span><\/p>\n

Durch den Einsatz von KI zur Modellierung molekularer Komponenten erm\u00f6glicht BioNeMo den Forschern die Entwicklung neuer molekularer Strukturen, die zu wirksamen Arzneimitteln f\u00fchren k\u00f6nnten, wodurch sich der Bedarf an kostspieligen, zeitaufw\u00e4ndigen physikalischen Experimenten verringert.\u00a0<\/span><\/p>\n

Nat\u00fcrlich werden alle diese Modelle und Services von der f\u00fchrenden KI-Hardware-Infrastruktur von NVIDIA unterst\u00fctzt.<\/span><\/p>\n

BioNeMo kommt zus\u00e4tzlich zu dem breiteren NVIDIA Clara-Plattform<\/a>. NVIDIA Clara ist eine auf das Gesundheitswesen zugeschnittene Computing-Plattform, die die Leistung von KI und fortschrittlichem Computing nutzen soll, um Herausforderungen im Gesundheitswesen zu bew\u00e4ltigen.\u00a0<\/span><\/p>\n

Die Clara-Plattform ist von zentraler Bedeutung f\u00fcr die generative KI-Strategie im Gesundheitswesen, die NVIDIA nach eigenen Angaben seit mehr als einem Jahrzehnt verfolgt. Sie bietet Tools und Frameworks, die speziell f\u00fcr Anwendungen in der medizinischen Bildgebung, Genomanalyse, Medikamentenentwicklung und anderen gesundheitsbezogenen Bereichen optimiert sind.\u00a0<\/span><\/p>\n

Kimberly Powell, NVIDIAs VP of Healthcare, erkl\u00e4rt zu BioNeMo: \"Das Gesundheitswesen ist von Natur aus kompliziert. Wir wollen es Forschern leichter machen, die diese Modelle auf eigenen Daten feinabstimmen, die KI-Modellinferenz \u00fcber Webbrowser oder Cloud-APIs ausf\u00fchren und auf vortrainierte Modelle f\u00fcr die Arzneimittelentwicklung zugreifen k\u00f6nnen.\"\u00a0<\/span><\/p>\n

Eine Auswahl von Biotech- und Gesundheitsmodellen<\/h2>\n

Die Palette der Tools in BioNeMo ist beeindruckend, von NVIDIAs MolMIM-Modell, das kleine Molek\u00fcle generieren kann, bis hin zu Recursions Phenom-Beta, einem f\u00fchrenden Modell f\u00fcr die Einbettung zellul\u00e4rer Mikroskopiebilder.\u00a0\u00a0<\/span><\/p>\n

Recursion ist das erste Unternehmen, das ein KI-Modell \u00fcber NVIDIAs BioNeMo Cloud APIs anbietet. Phenom-Beta extrahiert Merkmale aus zellul\u00e4ren Mikroskopiebildern und erm\u00f6glicht so tiefere Einblicke in zellul\u00e4re Funktionen und wie Zellen auf Medikamente oder genetische Ver\u00e4nderungen reagieren.<\/span><\/p>\n

\"NVIDIA
Phenom-Beta meistert Bildrekonstruktionsaufgaben, die die Leistung des Modells bewerten. Quelle: NVIDIA<\/a>.<\/figcaption><\/figure>\n

Nach Angaben von NVIDIA<\/span><\/a>Recursion erweitert seine Supercomputing-Ressourcen um mehr als 500 NVIDIA H100-Grafikprozessoren und vervierfacht damit die Rechenleistung des Systems. Damit wird es zu einem der leistungsst\u00e4rksten Supercomputer im biopharmazeutischen Sektor.<\/span><\/p>\n

Die Entdeckung von Arzneimitteln hat sich als eine der Hauptst\u00e4rken der generativen KI im wissenschaftlichen Sektor herausgestellt, wobei Modelle bei der Entdeckung von <\/span>neue Klassen von Antibiotika<\/span><\/a>identifizierend <\/span>Verbindungen, die den Alterungsprozess verlangsamen k\u00f6nnen<\/span><\/a>und <\/span>Entwicklung von Medikamenten gegen Krebs<\/span><\/a>.<\/span><\/p>\n

Mit ihrer F\u00e4higkeit, riesige Datenmengen zu verarbeiten und neue Erkenntnisse aus diesen Daten zu gewinnen, erf\u00fcllt die generative KI ihr namensgebendes Versprechen, neue Wege f\u00fcr die medizinische und biotechnologische Forschung zu er\u00f6ffnen.<\/span><\/p>\n

Dies kommt, da NVIDIA k\u00fcndigt neue GPUs und Hardware an<\/a> f\u00fcr lokale, ger\u00e4teinterne KI-Verarbeitung.<\/p>","protected":false},"excerpt":{"rendered":"

NVIDIA hat neue generative KI-Modelle zu BioNeMo hinzugef\u00fcgt, einem Cloud-Service zur Erstellung und Bereitstellung von KI-Modellen f\u00fcr die Arzneimittelforschung. BioNeMo ist eine generative KI-Plattform, die den Prozess der Arzneimittelentdeckung unterst\u00fctzen soll, f\u00fcr den KI im Jahr 2023 eine enorme Begabung gezeigt hat. Sie bietet eine Reihe von KI-Modellen und Cloud-Diensten, die speziell auf die Arzneimittelentwicklung zugeschnitten sind. Durch den Einsatz von KI zur Modellierung molekularer Komponenten erm\u00f6glicht BioNeMo den Forschern, neue molekulare Strukturen zu generieren, die zu wirksamen Medikamenten f\u00fchren k\u00f6nnten, wodurch die Notwendigkeit kostspieliger, zeitaufw\u00e4ndiger physikalischer Experimente reduziert wird. Nat\u00fcrlich werden alle diese Modelle und Dienste von NVIDIAs f\u00fchrender KI-Technologie unterst\u00fctzt.<\/p>","protected":false},"author":2,"featured_media":1059,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[203,260,204,101,106],"class_list":["post-9027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product","tag-biotech","tag-drug-discovery","tag-healthcare","tag-medtech","tag-nvidia"],"yoast_head":"\nNVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI<\/title>\n<meta name=\"description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/de\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\" \/>\n<meta property=\"og:description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/de\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-09T14:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-10T09:17:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sam Jeans\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sam Jeans\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"author\":{\"name\":\"Sam Jeans\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\"},\"headline\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"wordCount\":442,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"keywords\":[\"Biotech\",\"Drug discovery\",\"Healthcare\",\"MedTech\",\"Nvidia\"],\"articleSection\":[\"Product\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"description\":\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Nvidia AI products\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\",\"name\":\"Sam Jeans\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"caption\":\"Sam Jeans\"},\"description\":\"Sam is a science and technology writer who has worked in various AI startups. When he\u2019s not writing, he can be found reading medical journals or digging through boxes of vinyl records.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/sam-jeans-6746b9142\\\/\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/de\\\/author\\\/samjeans\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NVIDIA erweitert sein Angebot an Modellen f\u00fcr die Arzneimittelforschung durch BioNeMo | DailyAI","description":"NVIDIA hat neue generative KI-Modelle zu BioNeMo hinzugef\u00fcgt, einem Cloud-Service zur Erstellung und Bereitstellung von KI-Modellen f\u00fcr die Arzneimittelforschung.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/de\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_locale":"de_DE","og_type":"article","og_title":"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI","og_description":"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.","og_url":"https:\/\/dailyai.com\/de\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_site_name":"DailyAI","article_published_time":"2024-01-09T14:16:00+00:00","article_modified_time":"2024-01-10T09:17:28+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","type":"image\/jpeg"}],"author":"Sam Jeans","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Verfasst von":"Sam Jeans","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"author":{"name":"Sam Jeans","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9"},"headline":"NVIDIA expands offerings of drug discovery models through BioNeMo","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"wordCount":442,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","keywords":["Biotech","Drug discovery","Healthcare","MedTech","Nvidia"],"articleSection":["Product"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","url":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","name":"NVIDIA erweitert sein Angebot an Modellen f\u00fcr die Arzneimittelforschung durch BioNeMo | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","description":"NVIDIA hat neue generative KI-Modelle zu BioNeMo hinzugef\u00fcgt, einem Cloud-Service zur Erstellung und Bereitstellung von KI-Modellen f\u00fcr die Arzneimittelforschung.","breadcrumb":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","width":1000,"height":667,"caption":"Nvidia AI products"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"NVIDIA expands offerings of drug discovery models through BioNeMo"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"Ihre t\u00e4gliche Dosis an AI-Nachrichten","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9","name":"Sam Jeans","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","caption":"Sam Jeans"},"description":"Sam ist ein Wissenschafts- und Technologiewissenschaftler, der in verschiedenen KI-Startups gearbeitet hat. Wenn er nicht gerade schreibt, liest er medizinische Fachzeitschriften oder kramt in Kisten mit Schallplatten.","sameAs":["https:\/\/www.linkedin.com\/in\/sam-jeans-6746b9142\/"],"url":"https:\/\/dailyai.com\/de\/author\/samjeans\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/posts\/9027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/comments?post=9027"}],"version-history":[{"count":9,"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/posts\/9027\/revisions"}],"predecessor-version":[{"id":9063,"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/posts\/9027\/revisions\/9063"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/media\/1059"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/media?parent=9027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/categories?post=9027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/de\/wp-json\/wp\/v2\/tags?post=9027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}